These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 30462325)

  • 1. A novel approach to candidemia? The potential role of checkpoint inhibition.
    Mellinghoff SC; von Bergwelt-Baildon M; Schößer HA; Cornely OA
    Med Mycol; 2019 Feb; 57(2):151-154. PubMed ID: 30462325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.
    Carosella ED; Ploussard G; LeMaoult J; Desgrandchamps F
    Eur Urol; 2015 Aug; 68(2):267-79. PubMed ID: 25824720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of immune checkpoint cancer therapy after PD-1 and CTLA-4.
    Hahn AW; Gill DM; Pal SK; Agarwal N
    Immunotherapy; 2017 Jun; 9(8):681-692. PubMed ID: 28653573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors.
    Hargadon KM; Johnson CE; Williams CJ
    Int Immunopharmacol; 2018 Sep; 62():29-39. PubMed ID: 29990692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Checkpoint Blockade for the Treatment of Advanced Melanoma.
    Callahan MK; Flaherty CR; Postow MA
    Cancer Treat Res; 2016; 167():231-50. PubMed ID: 26601865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is earlier better for melanoma checkpoint blockade?
    Robert C
    Nat Med; 2018 Nov; 24(11):1645-1648. PubMed ID: 30401867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy 2.0: Improving the Response to Checkpoint Inhibitors.
    Friedrich MJ
    JAMA; 2019 Jan; 321(2):131-133. PubMed ID: 30566194
    [No Abstract]   [Full Text] [Related]  

  • 8. Immune checkpoint therapy for pancreatic cancer.
    Johansson H; Andersson R; Bauden M; Hammes S; Holdenrieder S; Ansari D
    World J Gastroenterol; 2016 Nov; 22(43):9457-9476. PubMed ID: 27920468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Checkpoint Inhibitors: Conquering Cancer with a Little (T)-Help from Our Microbial Friends.
    Asmar N; Ibrahim T; Rey JF
    Dig Dis Sci; 2018 Sep; 63(9):2177-2179. PubMed ID: 29982987
    [No Abstract]   [Full Text] [Related]  

  • 10. Nobel goes to immune checkpoint-Innovative cancer treatment by immunotherapy.
    Li J; Dong C
    Sci China Life Sci; 2018 Nov; 61(11):1445-1450. PubMed ID: 30377902
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanistic and pharmacologic insights on immune checkpoint inhibitors.
    Sweis RF; Luke JJ
    Pharmacol Res; 2017 Jun; 120():1-9. PubMed ID: 28323141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
    Spigel DR; Socinski MA
    J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical deployment of antibodies for treatment of melanoma.
    Curti BD; Urba WJ
    Mol Immunol; 2015 Oct; 67(2 Pt A):18-27. PubMed ID: 25746916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Checkpoint inhibitors in Hodgkin's lymphoma.
    Jezeršek Novaković B
    Eur J Haematol; 2016 Apr; 96(4):335-43. PubMed ID: 26560962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New checkpoint inhibitors ride the immunotherapy tsunami.
    Mullard A
    Nat Rev Drug Discov; 2013 Jul; 12(7):489-92. PubMed ID: 23812256
    [No Abstract]   [Full Text] [Related]  

  • 16. Immune checkpoint inhibitors: a new frontier in bladder cancer.
    Kates M; Sopko NA; Matsui H; Drake CG; Hahn NM; Bivalacqua TJ
    World J Urol; 2016 Jan; 34(1):49-55. PubMed ID: 26487055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy: a potential adjunctive treatment for fungal infection.
    Kullberg BJ; van de Veerdonk F; Netea MG
    Curr Opin Infect Dis; 2014 Dec; 27(6):511-6. PubMed ID: 25304393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Era of Immune Checkpoint Therapy: From Cancer to Viral Infection-A Mini Comment on the 2018 Medicine Nobel Prize.
    Liu J; Pan W; Yang D
    Virol Sin; 2018 Dec; 33(6):467-471. PubMed ID: 30570713
    [No Abstract]   [Full Text] [Related]  

  • 19. The immune checkpoint inhibitors: where are we now?
    Webster RM
    Nat Rev Drug Discov; 2014 Dec; 13(12):883-4. PubMed ID: 25345674
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationally combining immunotherapies to improve efficacy of immune checkpoint blockade in solid tumors.
    Dammeijer F; Lau SP; van Eijck CHJ; van der Burg SH; Aerts JGJV
    Cytokine Growth Factor Rev; 2017 Aug; 36():5-15. PubMed ID: 28693973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.